Montag A & Associates Inc Merck & Co., Inc. Transaction History

Montag A & Associates Inc

  • $2.09 Billion
  • Q3 2024

A detailed history of Montag A & Associates Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Montag A & Associates Inc holds 178,614 shares of MRK stock, worth $17.6 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
178,614
Previous 179,695 0.6%
Holding current value
$17.6 Million
Previous $22.2 Million 8.82%
% of portfolio
0.97%
Previous 1.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$111.15 - $128.97 $120,153 - $139,416
-1,081 Reduced 0.6%
178,614 $20.3 Million
Q2 2024

Jul 31, 2024
BUY
$123.8 - $132.96 $957,716 - $1.03 Million
7,736 Added 4.5%
179,695 $22.2 Million
Q1 2024

May 07, 2024
BUY
$113.24 - $131.95 $285,478 - $332,645
2,521 Added 1.49%
171,959 $22.7 Million
Q4 2023

Feb 07, 2024
BUY
$100.18 - $109.02 $65,417 - $71,190
653 Added 0.39%
169,438 $18.5 Million
Q3 2023

Nov 09, 2023
SELL
$102.95 - $114.33 $1.47 Million - $1.63 Million
-14,268 Reduced 7.79%
168,785 $17.4 Million
Q2 2023

Aug 09, 2023
BUY
$108.61 - $118.38 $11,078 - $12,074
102 Added 0.06%
183,053 $21.1 Million
Q1 2023

May 11, 2023
SELL
$102.94 - $114.86 $291,217 - $324,938
-2,829 Reduced 1.52%
182,951 $19.5 Million
Q4 2022

Feb 02, 2023
SELL
$87.44 - $112.11 $81,406 - $104,374
-931 Reduced 0.5%
185,780 $20.6 Million
Q3 2022

Nov 09, 2022
SELL
$84.53 - $94.96 $768,293 - $863,091
-9,089 Reduced 4.64%
186,711 $16.2 Million
Q2 2022

Aug 10, 2022
BUY
$83.49 - $94.64 $244,375 - $277,011
2,927 Added 1.52%
195,800 $18 Million
Q1 2022

May 02, 2022
BUY
$73.51 - $82.4 $154,223 - $172,875
2,098 Added 1.1%
192,873 $15.8 Million
Q4 2021

Feb 09, 2022
BUY
$72.28 - $90.54 $27,466 - $34,405
380 Added 0.2%
190,775 $14.6 Million
Q3 2021

Nov 08, 2021
BUY
$71.68 - $78.83 $1.21 Million - $1.33 Million
16,858 Added 9.71%
190,395 $14.3 Million
Q2 2021

Aug 03, 2021
SELL
$70.31 - $77.77 $179,290 - $198,313
-2,550 Reduced 1.45%
173,537 $13.5 Million
Q1 2021

May 14, 2021
SELL
$68.86 - $81.11 $744,996 - $877,529
-10,819 Reduced 5.79%
176,087 $13.6 Million
Q4 2020

Feb 12, 2021
BUY
$71.77 - $79.65 $209,209 - $232,179
2,915 Added 1.58%
186,906 $15.3 Million
Q3 2020

Nov 12, 2020
BUY
$73.18 - $82.95 $130,114 - $147,485
1,778 Added 0.98%
183,991 $15.3 Million
Q2 2020

Aug 04, 2020
SELL
$70.42 - $80.13 $168,092 - $191,270
-2,387 Reduced 1.29%
182,213 $14.1 Million
Q1 2020

May 06, 2020
SELL
$63.36 - $87.82 $2.23 Million - $3.09 Million
-35,188 Reduced 16.01%
184,600 $14.2 Million
Q4 2019

Feb 05, 2020
BUY
$77.58 - $87.54 $147,557 - $166,501
1,902 Added 0.87%
219,788 $20 Million
Q3 2019

Nov 04, 2019
BUY
$76.08 - $82.93 $897,744 - $978,574
11,800 Added 5.73%
217,886 $18.3 Million
Q2 2019

Aug 06, 2019
BUY
$69.84 - $81.59 $851,698 - $994,990
12,195 Added 6.29%
206,086 $17.3 Million
Q1 2019

May 01, 2019
SELL
$69.58 - $79.36 $967,996 - $1.1 Million
-13,912 Reduced 6.69%
193,891 $16.1 Million
Q4 2018

Feb 06, 2019
SELL
$65.24 - $75.71 $74,373 - $86,309
-1,140 Reduced 0.55%
207,803 $15.9 Million
Q3 2018

Nov 07, 2018
BUY
$57.69 - $67.84 $1.64 Million - $1.93 Million
28,473 Added 15.78%
208,943 $14.8 Million
Q2 2018

Aug 01, 2018
SELL
$50.83 - $59.72 $46,966 - $55,181
-924 Reduced 0.51%
180,470 $11 Million
Q1 2018

May 07, 2018
SELL
$50.96 - $59.23 $125,055 - $145,350
-2,454 Reduced 1.33%
181,394 $9.88 Million
Q4 2017

Feb 09, 2018
SELL
$51.62 - $61.64 $152,279 - $181,838
-2,950 Reduced 1.58%
183,848 $10.3 Million
Q3 2017

Nov 06, 2017
BUY
$58.67 - $63.13 $11 Million - $11.8 Million
186,798
186,798 $12 Million

Others Institutions Holding MRK

# of Institutions
3,803
Shares Held
1.9B
Call Options Held
13.5M
Put Options Held
11.1M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $250B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email